bicalutamide has been researched along with Adenoma, Prostatic in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (64.29) | 18.2507 |
| 2000's | 5 (35.71) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bedolla, RG; Ghosh, PM; Kreisberg, JI; Malik, SN; Mikhailova, M; Prihoda, TJ; Troyer, DA; Wang, Y | 1 |
| Blackledge, GR; Kennealey, GT; Strutt, KL | 1 |
| Eri, LM; Tveter, KJ | 2 |
| Eri, LM; Haug, E; Tveter, KJ | 1 |
| Tyrrell, CJ | 1 |
| Eri, LM; Urdal, P | 1 |
| Lepor, H | 1 |
| Akakura, K; Furuya, Y; Ito, H | 1 |
| Eri, LM; Svindland, A | 1 |
| Eri, LM; Svindland, A; Tveter, KJ | 1 |
| Adam, RM; Berger, UV; Brown, EM; Freeman, MR; Hediger, MA; Peng, JB; Williams, BJ; Zhuang, L | 1 |
| Berge, V; Eri, LM; Tysland, O; Wessel, N | 1 |
| Barbolt, TA; Batzold, FH; Hollenbaugh, DM; Juniewicz, PE; Lemp, BM; McCarthy, M; Reel, JR; Shaw, C; Winneker, RC | 1 |
2 review(s) available for bicalutamide and Adenoma, Prostatic
| Article | Year |
|---|---|
Medical therapy for benign prostatic hyperplasia.
Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Androgen Antagonists; Anilides; Clinical Trials as Topic; Humans; Male; Nitriles; Phenoxybenzamine; Prazosin; Prostatic Hyperplasia; Tosyl Compounds | 1993 |
[Steroidal and nonsteroidal antiandrogens: chemical structures, mechanisms of action and clinical applications].
Topics: Androgen Antagonists; Anilides; Chlormadinone Acetate; Flutamide; Humans; Male; Neoplasms, Hormone-Dependent; Nitriles; Prostatic Hyperplasia; Prostatic Neoplasms; Tosyl Compounds | 1998 |
6 trial(s) available for bicalutamide and Adenoma, Prostatic
| Article | Year |
|---|---|
Re: A prospective, placebo-controlled study of the antiandrogen Casodex as treatment for patients with benign prostatic hyperplasia.
Topics: Androgen Antagonists; Anilides; Animals; Humans; Male; Mice; Nitriles; Prospective Studies; Prostatic Hyperplasia; Tosyl Compounds | 1994 |
Safety, side effects and patient acceptance of the antiandrogen Casodex in the treatment of benign prostatic hyperplasia.
Topics: Aged; Androgen Antagonists; Anilides; Double-Blind Method; Humans; Libido; Male; Middle Aged; Nitriles; Penile Erection; Prostatic Hyperplasia; Sexual Dysfunction, Physiological; Tosyl Compounds | 1994 |
Effects on the endocrine system of long-term treatment with the non-steroidal anti-androgen Casodex in patients with benign prostatic hyperplasia.
Topics: Aged; Androgen Antagonists; Androstenedione; Anilides; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dihydrotestosterone; Double-Blind Method; Estradiol; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Male; Nitriles; Prolactin; Prostatic Hyperplasia; Testosterone; Tosyl Compounds | 1995 |
Tolerability and quality of life aspects with the anti-androgen Casodex (ICI 176,334) as monotherapy for prostate cancer. International Casodex Investigators.
Topics: Androgen Antagonists; Anilides; Antineoplastic Agents; Double-Blind Method; Humans; Libido; Male; Nitriles; Penile Erection; Prostatic Hyperplasia; Prostatic Neoplasms; Quality of Life; Tosyl Compounds | 1994 |
Effects of the nonsteroidal antiandrogen Casodex on lipoproteins, fibrinogen and plasminogen activator inhibitor in patients with benign prostatic hyperplasia.
Topics: Aged; Androgen Antagonists; Anilides; Apolipoprotein A-I; Apolipoproteins B; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Double-Blind Method; Estradiol; Fibrinogen; Humans; Lipoproteins; Luteinizing Hormone; Male; Middle Aged; Nitriles; Plasminogen Activator Inhibitor 1; Prostatic Hyperplasia; Risk Factors; Testosterone; Tosyl Compounds; Triglycerides | 1995 |
A prospective, placebo-controlled study of the antiandrogen Casodex as treatment for patients with benign prostatic hyperplasia.
Topics: Aged; Androgen Antagonists; Anilides; Double-Blind Method; Humans; Male; Nitriles; Prospective Studies; Prostate; Prostatic Hyperplasia; Tosyl Compounds; Urodynamics | 1993 |
6 other study(ies) available for bicalutamide and Adenoma, Prostatic
| Article | Year |
|---|---|
Signal transduction pathways in androgen-dependent and -independent prostate cancer cell proliferation.
Topics: Androgen Antagonists; Androgen Receptor Antagonists; Androgens; Anilides; Antibiotics, Antineoplastic; Cell Proliferation; Enzyme Inhibitors; Humans; Ki-67 Antigen; Male; Mitogen-Activated Protein Kinases; Neoplasms, Hormone-Dependent; Nitriles; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Prostatic Hyperplasia; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Protein Kinases; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Receptors, Androgen; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases; Tosyl Compounds; Tumor Cells, Cultured | 2005 |
Can prostate epithelial content predict response to hormonal treatment of patients with benign prostatic hyperplasia?
Topics: Aged; Androgen Antagonists; Anilides; Biopsy; Delayed-Action Preparations; Epithelium; Humans; Leuprolide; Male; Nitriles; Probability; Prostate; Prostatic Hyperplasia; Tosyl Compounds; Treatment Outcome; Ultrasonography; Urodynamics | 2000 |
The effect of bicalutamide on prostate histology.
Topics: Aged; Androgen Antagonists; Anilides; Antineoplastic Agents; Drug Administration Schedule; Humans; Male; Microscopy; Middle Aged; Nitriles; Prostatic Hyperplasia; Tosyl Compounds; Treatment Outcome | 2001 |
CaT1 expression correlates with tumor grade in prostate cancer.
Topics: Androgen Antagonists; Androgens; Anilides; Base Sequence; Calcium Channels; Calcium Signaling; Cell Line; DNA Primers; Epithelial Cells; Gene Expression Regulation, Neoplastic; Humans; In Situ Hybridization; Male; Nitriles; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; RNA, Messenger; RNA, Neoplasm; Tosyl Compounds; TRPV Cation Channels; Tumor Cells, Cultured | 2001 |
Comparative study of pressure-flow parameters.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Anilides; Controlled Clinical Trials as Topic; Diagnostic Techniques, Urological; Humans; Leuprolide; Male; Medical Records; Middle Aged; Muscle Hypertonia; Nitriles; Pressure; Prostatic Hyperplasia; Reproducibility of Results; Retrospective Studies; Tosyl Compounds; Treatment Outcome; Urinary Bladder Neck Obstruction; Urodynamics | 2002 |
The effect of the steroidal androgen receptor antagonist, Win 49,596, on the prostate and testis of beagle dogs.
Topics: 5-alpha Reductase Inhibitors; Androgen Antagonists; Androstenes; Anilides; Animals; Azasteroids; DNA; Dogs; Finasteride; Hypertrophy; Male; Nitriles; Orchiectomy; Organ Size; Pregnanes; Prostate; Prostatic Hyperplasia; Pyrazoles; Receptors, Androgen; Semen; Spermatogenesis; Testis; Testosterone; Tosyl Compounds; Ultrasonography | 1990 |